Matthew K. Szot - Jan 23, 2025 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Financial Officer
Signature
/s/ Matthew K. Szot
Stock symbol
CVKD
Transactions as of
Jan 23, 2025
Transactions value $
$0
Form type
4
Date filed
1/24/2025, 06:10 PM
Previous filing
Aug 28, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +50K $0.00 50K Jan 23, 2025 Common Stock 50K $19.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of options to purchase 50,000 shares of common stock, which shall vest 1/4 on February 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.